mHealth technology has the potential to transform the way biopharma conducts clinical trials and perhaps to disrupt the clinical development of medicines altogether. Experts say that mHealth will positively impact the accuracy, frequency, convenience, and safety of clinical data. We asked respondents how committed their companies are to using various approaches to mHealth for their interventional or observational clinical trial protocols.
Click here to access a printer-friendly version of this infographic.
View Resource